References
- Hall DG. Boronic acids. New York: John Wiley and Sons; 2005
- Haveric S, Haveric A, Bajrovic K, et al. Effects of dipotassium-trioxohydroxytetrafluorotriborate (K2[B3O3F4OH]) on genetic material and inhibition of cell division in human cell cultures. Drug Chem Toxicol 2001;34:250–4
- Galic B. Boroxine composition for removal of skin changes. United States Patent (2012) US 8 278 289
- Galic B. Removal of skin changes. European Patent (2013) EP 1 996 514
- Adams JA, Behnke M, Chen S, et al. Potent and selective inhibitors of the proteasome: dipeptidyl boronic acid. Bioorg Med Chem Lett 1998;8:333–8
- Paramore A, Frantz S. Bortezomid. Nat Rev Drug Discov 2003;2:611–2
- Deisseroth A, Dounce AL. Catalase: physical and chemical properties, mechanism of catalysis, and physiological role. Physiol Rev 1970;50:319–75
- Kirkman HN, Gaetani GF. Mammalian catalase: a venerable enzyme with new mysteries. Trends Biochem Sci 2007;32:44–50
- Omar RA, Chyan YJ, Andorn AC, et al. Increased expression but reduced activity of antioxidant enzymes in Alzheimer’s Disease. J Alzheimers Dis 1999;1:139–45
- Góth L, Lenkey A, Bigler WN. Blood catalase deficiency and diabetes in Hungary. Diabetes Care 2001;24:1839–40
- Leopold JA, Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 2005;25:1332–40
- Valko M, Rhodes CJ, Moncol J, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1–40
- Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44–84
- Ryss IG, Slutskaya MM. Report on the platinum sector. Akad Nauk SSSR 1951;26:216--18
- Schubert WM. The aromatic elimination reaction. I. Mechanism of the decarboxylation of mesitoic acid. J Am Chem Soc 1949;71:2639–44
- Chance B. An intermediate compound in the catalase-hydrogen peroxide interaction. Acta Chem Scand 1947;1:236–67
- Sizer IW. Temperature activation and inactivation of the crystalline catalase-hydrogen peroxide system. J Biol Chem 1944;154:461–73
- Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1977;37:517–54
- D’Autréaux B, Toledano MB. ROS as signaling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007;8:813–24
- Korotkina RN, Matskevich GN, Devlikanova AS, et al. Activity of glutathione-metabolizing and antioxidant enzymes in malignant and benign tumors of human lungs. Bull Exp Biol Med 2002;133:606–8
- Kahlos K, Soini Y, Sormunen R, et al. Expression and prognostic significance of catalase in malignant mesothelioma. Cancer 2001;91:1349–57
- Falkson G, De Jager ME. Catalase activity in the epidermis of patients with advanced cancer. Nature 1964;202:203--4
- Góth L, Rass P, Páy A. Catalase enzyme mutations and their association with diseases. Mol Diagn 2004;8:141–9
- Ho YS, Xiong Y, Ma W, et al. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 2004;279:32804–12
- Milton GNN. Homocysteine inhibits hydrogen peroxide breakdown by catalase. Open Enzym Inhib J 2008;l:34–41